M-CARES will use large-scale administrative data complemented by follow-up surveys and a randomized control trial (RCT) to estimate the causal impact of greater financial access to contraception on a comprehensive set of outcomes. Outcomes include contraceptive use, pregnancy, childbearing, and parenting strategies; partnership decisions and relationship quality; health and health care use; education, labor market success, and public assistance receipt; financial security; neighborhood quality; mental health and stress; and life plans. The resulting estimates will inform a more complete understanding of the costs and benefits of financial access to contraception and, therefore, the investment value of related policies and programs.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of patients billing for use of any contraception (1 for use of contraception/0 no use of contraception)
Timeframe: 100 days from enrollment
Incidence of patients billing for long-run acting, reversible contraception (LARC) (0 no use of LARC/1 for use of LARC)
Timeframe: 100 days from enrollment
Incidence of patients billing for long-run acting, reversible contraception (LARC) (0 no use of LARC/1 for use of LARC)
Timeframe: Up to 1 year post enrollment
Incidence of pregnancy up to 1 year post enrollment
Timeframe: Up to 1 year post-enrollment
Incidence of pregnancy up to 3 years post enrollment
Timeframe: Up to 3 year post-enrollment
Incidence of childbirth up to 1 year post enrollment
Timeframe: Up to 1 years post enrollment
Incidence of childbirth up to 3 year post enrollment
Timeframe: Up to 3 years post enrollment